会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • SYSTEMS AND METHODS FOR SHELL ENCAPSULATION
    • 用于壳体封装的系统和方法
    • EP2750787A2
    • 2014-07-09
    • EP12751233.3
    • 2012-08-15
    • President and Fellows of Harvard CollegeBASF SE
    • WEITZ, David, A.SHUM, Ho, CheungZHAO, YuanjinSUN, BingjieHOLTZE, Christian
    • B01J13/20
    • B01J13/203A01N25/28A23L29/015A23P10/30A61K9/501A61K9/5036A61K9/5089C09B67/0097C11D17/0039A01N59/02A01N59/06A01N59/16
    • The present invention generally relates to particles, including particles for drug delivery and other applications. Certain aspects of the invention are generally directed to particles comprising a shell and an interior at least partially contained by the shell. In some embodiments, the particles may be treated to enhance the containment of the interior, for example to reduce transport of an agent into or out of the interior. Such particles may exhibit increased ability to encapsulate agents and/or increased storage life (e.g., due to reduced leakage). For instance, in certain embodiments, any defects, such as cracks, pores, etc. within the shell may be sealed or otherwise treated to reduce transport therethrough, for example, with a solid. In some embodiments, for instance, a first reactant in the interior of a particle may come into contact with a second reactant outside of the particle to form a solid, or other suitable product. The shell may also be treated, e.g., at a later point in time, to cause release of an agent contained within the interior, in certain aspects. For example, the shell may be heated to cause the release of the agent from the particle, or the shell may be exposed to chemical or enzymatic degradation, or a change in osmolarity, to cause release of an agent. Still other aspects of the present invention are generally directed to methods of making or using such particles, kits or devices including such particles, or the like.
    • 本发明一般涉及颗粒,包括用于药物递送和其他应用的颗粒。 本发明的某些方面通常涉及包含壳和至少部分由壳包含的内部的颗粒。 在一些实施方案中,可对颗粒进行处理以增强内部的容纳,例如以减少试剂进入或离开内部的运输。 这样的颗粒可以表现出增加的包封剂的能力和/或增加的存储寿命(例如,由于泄漏降低)。 例如,在某些实施例中,壳体内的任何缺陷(例如裂纹,孔隙等)可被密封或以其他方式处理以减少通过其中的运输,例如用固体。 在一些实施例中,例如,颗粒内部的第一反应物可以与颗粒外部的第二反应物接触以形成固体或其他合适的产物。 在某些方面,壳还可以例如在稍后的时间点被处理,以引起包含在内部内的试剂的释放。 例如,壳可以被加热以引起药剂从颗粒中释放,或壳可以暴露于化学或酶降解或渗透压变化,以引起药剂的释放。 本发明的其他方面通常涉及制造或使用这种颗粒,包括这种颗粒的试剂盒或装置等的方法。
    • 3. 发明公开
    • PARTICLES FOR DRUG DELIVERY AND OTHER APPLICATIONS
    • 用颗粒释放活性和其他应用程序
    • EP2608772A2
    • 2013-07-03
    • EP11749695.0
    • 2011-08-23
    • President and Fellows of Harvard CollegeBASF SE
    • FAN, BenKOLTZENBURG, Roland, S.RIEGER, Jens, B.WEITZ, David, A.
    • A61K9/14A61K9/16A61K31/565A61K31/58
    • A61K9/143A61K9/1694A61K31/565A61K31/58
    • The present invention generally relates to particles for drug delivery and other applications. In one aspect, the present invention relates to a technique for reacting precursor compounds in the presence of a pharmaceutically- active agent to form product (e.g., in the form of particles) in which the agent is substantially contained within the product, and the product is soluble within typical gastric fluid of a mammal. In another aspect, the present invention is generally directed to particles comprising an inorganic pharmaceutically acceptable carrier, such as CaCO
      3 , and an agent. In some cases, at least some of the agent contained within the particles is fluidically inaccessible from externally of the particle. For instance, the agent may be present in isolated domains within the particle. In another aspect, the present invention is generally directed to methods of creating particles. For instance, according to one set of embodiments, two fluids containing reactants are mixed where, upon reaction of the reactants, an insoluble product is formed, which precipitates to form particles. In one example, a first fluid containing dissolved carbonate ions and a second fluid containing dissolved calcium ions and a pharmaceutically- active agent are mixed together; upon mixing of the first and second fluids, the calcium ions and the carbonate ions form calcium carbonate, which precipitates to form a co-precipitate with the pharmaceutically- active agent. Yet other aspects of the present invention are directed to particles formed from such reactions, methods of using such reactions, methods of promoting such reactions, kits involving particles, or the like.
    • 9. 发明公开
    • MULTIPLE EMULSIONS CREATED USING JUNCTIONS
    • 几种化合物生产的乳液
    • EP2473262A2
    • 2012-07-11
    • EP10814398.3
    • 2010-09-01
    • President and Fellows of Harvard CollegeBASF SE
    • WEITZ, David, A.ROMANOWSKY, MarkHOLTZE, Christian
    • B01F5/00B01F3/08B01F15/04
    • B01F13/0084B01F3/0807B01F2003/0838Y10T137/0318Y10T137/87571
    • The present invention generally relates to emulsions, and more particularly, to multiple emulsions. In one aspect, multiple emulsions are formed using a plurality of channels, such as microfluidic channels, that meet at a common intersection. The multiple emulsions may be created at a single common intersection in some embodiments, unlike other prior art systems where multiple channel intersections are required to create multiple emulsions. For instance, in one set of embodiments, three, four, or more microfluidic channels may intersect at a common intersection, with two or three serving as inlets and one serving as the outlet. In some embodiments, a first fluidic channel may be relatively hydrophobic, while a second fluidic channel is relatively hydrophilic. The third channel, if present, may be relatively hydrophilic or hydrophobic, depending on the application. The outlet channel may be hydrophobic, hydrophilic, or may comprise at least one portion that is relatively hydrophilic and at least one portion that is relatively hydrophilic. By controlling the flow of fluids through the hydrophilic and hydrophobic portions of the channels, multiple emulsions may be created proximate the common intersection, due to interactions between the fluids entering the common intersection. In other embodiments, different patterns of hydrophilic or hydrophobic channels may be used. Other aspects of the invention are generally directed to methods of making and using such systems, kits involving such systems, emulsions created using such systems, or the like.